Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144


The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials.

Anker SD, Agewall S, Borggrefe M, Calvert M, Jaime Caro J, Cowie MR, Ford I, Paty JA, Riley JP, Swedberg K, Tavazzi L, Wiklund I, Kirchhof P.

Eur Heart J. 2014 Aug 7;35(30):2001-9. doi: 10.1093/eurheartj/ehu205. Epub 2014 Jun 5. Review.


Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries.

Van Der Wees PJ, Nijhuis-Van Der Sanden MW, Ayanian JZ, Black N, Westert GP, Schneider EC.

Milbank Q. 2014 Dec;92(4):754-75. doi: 10.1111/1468-0009.12091.


Including patient-reported outcomes and patient-reported resource-use questionnaires in studies.

Bresnahan BW, Rundell SD.

Acad Radiol. 2014 Sep;21(9):1129-37. doi: 10.1016/j.acra.2014.05.008. Review.


Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper.

Baiardini I, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens W, van Wijk RG, La Grutta S, Lombardi C, Maurer M, Pinto AM, Ridolo E, Senna GE, Terreehorst I, Bom AT, Bousquet J, Zuberbier T, Braido F; Global Allergy and Asthma European Network.

Allergy. 2010 Mar;65(3):290-5. doi: 10.1111/j.1398-9995.2009.02263.x. Epub 2009 Nov 20.


Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.

Banerjee AK, Okun S, Edwards IR, Wicks P, Smith MY, Mayall SJ, Flamion B, Cleeland C, Basch E; Patient-Reported Outcomes Safety Event Reporting (PROSPER) Consortium.

Drug Saf. 2013 Dec;36(12):1129-49. doi: 10.1007/s40264-013-0113-z.


Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review.

Rahimi K, Malhotra A, Banning AP, Jenkinson C.

BMJ. 2010 Nov 1;341:c5707. doi: 10.1136/bmj.c5707. Review.


Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic.

Gilbert A, Sebag-Montefiore D, Davidson S, Velikova G.

Gynecol Oncol. 2015 Mar;136(3):429-39. doi: 10.1016/j.ygyno.2014.11.071. Epub 2014 Nov 28. Review.


The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.

Ahmed S, Berzon RA, Revicki DA, Lenderking WR, Moinpour CM, Basch E, Reeve BB, Wu AW; International Society for Quality of Life Research.

Med Care. 2012 Dec;50(12):1060-70. doi: 10.1097/MLR.0b013e318268aaff.


Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.

Korczak D, Dietl M, Steinhauser G.

GMS Health Technol Assess. 2011 Apr 1;7:Doc02. doi: 10.3205/hta000093.


Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research.

Snyder CF, Jensen RE, Segal JB, Wu AW.

Med Care. 2013 Aug;51(8 Suppl 3):S73-9. doi: 10.1097/MLR.0b013e31829b1d84.


The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice.

Calvert M, Brundage M, Jacobsen PB, Sch├╝nemann HJ, Efficace F.

Health Qual Life Outcomes. 2013 Oct 29;11:184. doi: 10.1186/1477-7525-11-184.


Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain.

Cheng JS, Lee MJ, Massicotte E, Ashman B, Gruenberg M, Pilcher LE, Skelly AC.

Spine (Phila Pa 1976). 2011 Oct 1;36(21 Suppl):S144-63. doi: 10.1097/BRS.0b013e31822ef5b4. Review.


Training clinicians in how to use patient-reported outcome measures in routine clinical practice.

Santana MJ, Haverman L, Absolom K, Takeuchi E, Feeny D, Grootenhuis M, Velikova G.

Qual Life Res. 2015 Jul;24(7):1707-18. doi: 10.1007/s11136-014-0903-5. Epub 2015 Jan 15.


The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory?

Greenhalgh J, Long AF, Flynn R.

Soc Sci Med. 2005 Feb;60(4):833-43. Review.


Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, L├╝hmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.


The prognostic significance of patient-reported outcomes in cancer clinical trials.

Gotay CC, Kawamoto CT, Bottomley A, Efficace F.

J Clin Oncol. 2008 Mar 10;26(8):1355-63. doi: 10.1200/JCO.2007.13.3439. Epub 2008 Jan 28. Review.


Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper.

Braido F, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens W, Gerth van Wijk R, La Grutta S, Lombardi C, Maurer M, Pinto AM, Ridolo E, Senna GE, Terreehorst I, Todo Bom A, Bousquet J, Zuberbier T, Baiardini I.

Allergy. 2010 Aug;65(8):959-68. doi: 10.1111/j.1398-9995.2010.02383.x. Epub 2010 May 10.


Clinician's checklist for reading and using an article about patient-reported outcomes.

Wu AW, Bradford AN, Velanovich V, Sprangers MA, Brundage M, Snyder C.

Mayo Clin Proc. 2014 May;89(5):653-61. doi: 10.1016/j.mayocp.2014.01.017. Epub 2014 Apr 3. Review.

Items per page

Supplemental Content

Write to the Help Desk